- Home
- ADXN vs IMCC Comparison
ADXN vs IMCC Comparison
Compare ADXN & IMCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ADXN | IMCC |
|---|---|---|
| Founded | 2002 | 1980 |
| Country | Switzerland | Israel |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medicinal Chemicals and Botanical Products |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.3M | 10.4M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | ADXN | IMCC |
|---|---|---|
| Price | $7.90 | $1.41 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 7.2K | ★ 286.1K |
| Earning Date | 12-04-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $198,824.00 | ★ $37,606,703.00 |
| Revenue This Year | $86.57 | $47.12 |
| Revenue Next Year | N/A | $12.83 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 1.92 |
| 52 Week Low | $6.51 | $0.93 |
| 52 Week High | $12.05 | $7.12 |
Technical Indicators
Market Signals| Indicator | ADXN | IMCC |
|---|---|---|
| Relative Strength Index (RSI) | 50.09 | 45.21 |
| Support Level | $7.47 | $1.35 |
| Resistance Level | $8.30 | $1.61 |
| Average True Range (ATR) | 0.50 | 0.24 |
| MACD | 0.09 | -0.03 |
| Stochastic Oscillator | 60.10 | 17.81 |
Price Performance
Historical ComparisonAbout ADXN Addex Therapeutics Ltd
Addex Therapeutics Ltd is a clinical-stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment, which is the discovery, development, and commercialization of small-molecule pharmaceutical products.
About IMCC IM Cannabis Corp.
IM Cannabis Corp is a Canada-based international medical cannabis company. It operates in the field of medical cannabis, through Focus Medical Herbs Ltd. (Focus), which holds a cultivation license to breed, grow, and supply medical cannabis products The majority of its revenues are generated from sales of medical cannabis products to customers in Israel. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany. Geographically, the majority is from Israel.